抗生素治疗儿童肺炎临床试验中受试者与非受试者结局相当:一项回顾性队列研究
该回顾性队列研究在肯尼亚六家医院纳入2-59月龄儿童,比较参与口服阿莫西林与苄青霉素随机对照试验的527例受试者与接受常规治疗的1182例非受试者的特征与结局,以评估试验结果的外部有效性。受试者喘息史更常见(35.4% vs 11.2%,P<0.01),非受试者脱水更常见(8.6% vs 5.9%,P=0.05),其余特征均衡。非受试者死亡14/1140(1.2%),受试者死亡4/527(0.8%),校正比值比为0.7(95%CI:0.2-2.1)。
要点
- 受试者喘息史更常见(35.4% vs 11.2%,P<0.01),非受试者脱水更常见(8.6% vs 5.9%,P=0.05)。
- 非受试者死亡14/1140(1.2%),受试者死亡4/527(0.8%),校正OR为0.7(95%CI:0.2-2.1)。
- 受试者与非受试者特征相似且死亡率均低,支持世界卫生组织修订的胸凹陷肺炎治疗推荐。
核心结论
- 试验受试者与非受试者患者特征相似,且两组死亡率均低。
- 这些发现支持世界卫生组织修订的胸凹陷肺炎治疗推荐。
研究设计与样本
- 回顾性队列研究,在肯尼亚六家医院纳入2-59月龄住院儿童。
- 共纳入1709例儿童,其中527例入组比较口服阿莫西林与苄青霉素的随机对照试验,1182例接受常规治疗。
- 非受试者数据在随机对照试验结束后从住院记录中提取。
- 采用多变量模型比较试验受试者与非受试者的死亡率。
主要发现
- 受试者喘息史更常见(35.4% vs 11.2%,P<0.01),非受试者脱水更常见(8.6% vs 5.9%,P=0.05)。
- 其他患者特征在两组间均衡。
- 在结局数据可获取者中,非受试者死亡14/1140(1.2%),受试者死亡4/527(0.8%)。
- 校正比值比为0.7(95%CI:0.2-2.1)。
关键数值与推荐
- 受试者喘息史35.4% vs 非受试者11.2%(P<0.01)。
- 非受试者脱水8.6% vs 受试者5.9%(P=0.05)。
- 非受试者死亡14/1140(1.2%)vs 受试者死亡4/527(0.8%),校正OR 0.7(95%CI:0.2-2.1)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We compared characteristics and outcomes of children enrolled in a randomized controlled trial (RCT) comparing oral amoxicillin and benzyl penicillin for the treatment of chest indrawing pneumonia vs. children who received routine care to determine the external validity of the trial results. STUDY DESIGN AND SETTING: A retrospective cohort study was conducted among children aged 2-59 months admitted in six Kenyan hospitals. Data for nontrial participants were extracted from inpatient records upon conclusion of the RCT. Mortality among trial vs. nontrial participants was compared in multivariate models. RESULTS: A total of 1,709 children were included, of whom 527 were enrolled in the RCT and 1,182 received routine care. History of a wheeze was more common among trial participants (35.4% vs. 11.2%; P < 0.01), while dehydration was more common among nontrial participants (8.6% vs. 5.9%; P = 0.05). Other patient characteristics were balanced between the two groups. Among those with available outcome data, 14/1,140 (1.2%) nontrial participants died compared to 4/527 (0.8%) enrolled in the trial (adjusted odds ratio, 0.7; 95% confidence interval: 0.2-2.1). CONCLUSION: Patient characteristics were similar, and mortality was low among trial and nontrial participants. These findings support the revised World Health Organization treatment recommendations for chest indrawing pneumonia.
引用
- Agweyu A, Oliwa J, Gathara D, et al. Comparable outcomes among trial and nontrial participants in a clinical trial of antibiotics for childhood pneumonia: a retrospective cohort study. J Clin Epidemiol. 2017. PMID: 29097339. doi:10.1016/j.jclinepi.2017.10.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。